Document is current
Any future updates will be listed below
-
Authors
Mathur, Anukriti https://orcid.org/0000-0002-7004-301X
Kay, Callum https://orcid.org/0000-0002-0985-6206
Xue, Yansong
Pandey, Abhimanu https://orcid.org/0000-0002-2367-3422
Lee, Jiwon https://orcid.org/0000-0003-2382-2106
Jing, Weidong https://orcid.org/0000-0002-6747-6076
Enosi Tuipulotu, Daniel https://orcid.org/0000-0002-6442-4633
Lo Pilato, Jordan https://orcid.org/0000-0003-4042-0934
Feng, Shouya
Ngo, Chinh
Zhao, Anyang https://orcid.org/0000-0001-8907-1048
Shen, Cheng https://orcid.org/0000-0002-6098-1205
Rug, Melanie https://orcid.org/0000-0002-4687-9677
Miosge, Lisa A
Atmosukarto, Ines I
Price, Jason D
Ali, Sidra A
Gardiner, Elizabeth E https://orcid.org/0000-0001-9453-9688
Robertson, Avril AB https://orcid.org/0000-0002-9652-8357
Awad, Milena M https://orcid.org/0000-0002-9275-3979
Lyras, Dena https://orcid.org/0000-0003-2345-9271
Kaakoush, Nadeem O https://orcid.org/0000-0003-4017-1077
Man, Si Ming https://orcid.org/0000-0002-5079-2857
-
Funding
Funding for this research was provided by:
CSL Limited
DHAC|National Health and Medical Research Council (APP1141504)
DHAC|National Health and Medical Research Council (APP1162103)
DHAC|National Health and Medical Research Council (APP1163358)
Gretel and Gordon Bootes Medical Research and Education Foundation
- License Information
-
More Information
Article History
Received: 4 January 2022
Revised: 18 March 2023
Accepted: 24 March 2023
First Online: 19 April 2023
Disclosure and competing interests statement
: I.I.A. is Director of Lipotek, a niche biotech company with a focus on liposome technology. I.I.A. and J.D.P. are shareholders of Lipotek. A.A.B.R. is a named inventor on inflammasome inhibitor patents (WO2018215818, WO2017140778 and WO2016131098). All other authors have no conflict of interest.
